ScholarIQanswers from OpenAlex & ORCID
Silvia La Monica
ResearcherPublications, citations & collaboration network
Silvia La Monica is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Silvia La Monica have?
ScholarIQindexed works
Silvia La Monica has 96 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Silvia La Monica have?
ScholarIQcitation count
Silvia La Monica has 2,936 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Silvia La Monica?
ScholarIQh-index
Silvia La Monica has an h-index of 35 in OpenAlex.
What is the i10-index of Silvia La Monica?
ScholarIQi10-index
Silvia La Monica has an i10-index of 59 in OpenAlex.
What is the ORCID of Silvia La Monica?
ScholarIQorcid
The ORCID for Silvia La Monica is on the source record.
What is the OpenAlex record for Silvia La Monica?
ScholarIQopenalex
The OpenAlex for Silvia La Monica is on the source record.
What are the most-cited papers on Silvia La Monica?
ScholarIQmost cited works
Human myeloma cells stimulate the receptor activator of nuclear factor-κB ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease
Nicola Giuliani, Simona Colla, Roberto Sala, Matteo Moroni, Mirca Lazzaretti, Silvia La Monica, Sabrina Bonomini, Magda Hojden, Gabriella Sammarelli, Sophie Barillé‐Nion, Régis Bataille, Vittorio Rizzoli
The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells
Daniele Cretella, Andrea Ravelli, Claudia Fumarola, Silvia La Monica, Graziana Digiacomo, Andrea Cavazzoni, Roberta Alfieri, Alessandra Biondi, Daniele Generali, Mara Bonelli, Pier Giorgio Petronini
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells
Mara Bonelli, Graziana Digiacomo, Claudia Fumarola, Roberta Alfieri, Federico Quaini, Angela Falco, Denise Madeddu, Silvia La Monica, Daniele Cretella, Andrea Ravelli, Paola Ulivi, Michela Tebaldi, Daniele Calistri, Angelo Delmonte, Luca Ampollini, Paolo Carbognani, Marcello Tiseo, Andrea Cavazzoni, Pier Giorgio Petronini
Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation
Mara Bonelli, Silvia La Monica, Claudia Fumarola, Roberta Alfieri
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines
Silvia La Monica, Daniele Cretella, Mara Bonelli, Claudia Fumarola, Andrea Cavazzoni, Graziana Digiacomo, Lisa Flammini, Elisabetta Barocelli, Roberta Minari, Nadia Naldi, Pier Giorgio Petronini, Marcello Tiseo, Roberta Alfieri